What Researchers Did
This review outlined the role of routine pulmonary imaging before hyperbaric oxygen treatment.
What They Found
Respiratory injury during hyperbaric oxygen treatment (HBOT) is rare, occurring mainly in patients with known underlying lung pathology. Routine chest X-rays have low sensitivity and high false negative rates for identifying pulmonary abnormalities, while CT scans, despite greater sensitivity, lead to a high false positive rate due to incidental findings. Consequently, routine pulmonary imaging for low-risk patients without a pertinent medical history or cardiorespiratory symptoms is considered of low value.
What This Means for Canadian Patients
Canadian patients undergoing hyperbaric oxygen treatment (HBOT) without a history of lung disease or symptoms may not require routine pre-treatment chest X-rays or CT scans. This approach could help avoid unnecessary radiation exposure and reduce healthcare costs while maintaining patient safety, as severe respiratory complications are rare in low-risk individuals.
Canadian Relevance
This study is relevant to Canadian patients and healthcare providers, as several authors are affiliated with Canadian institutions. The findings directly inform best practices for hyperbaric oxygen treatment protocols across Canada.
Study Limitations
As a review, this study synthesizes existing literature without presenting new empirical data on the efficacy of screening protocols.